Search research articles
Contact Us
Filters
Showing results (1-10 of 272) with videos related to
Page
of 28
Sort By:
Pediatric Annals
|
April 2, 2026
Burn and Scald Injuries: Prevention and Anticipatory Guidance
David Hong
Journal of Immunotherapy and Precision Oncology
|
September 2, 2024
How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience
Razelle Kurzrock, David Hong
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 28, 2019
Hypersensitivity to monoclonal antibodies used for cancer and inflammatory or connective tissue diseases
David Hong, David E Sloane
Current Allergy and Asthma Reports
|
June 24, 2016
Immediate Drug Hypersensitivity
Paige G Wickner, David Hong
International Journal of Hematology
|
December 16, 2011
Anticoagulation-induced severe bleeding in a patient receiving bevacizumab therapy
Javier Munoz, David Hong, Razelle Kurzrock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2017
Phase I Trial: SABR and Ipilimumab-Response
Chad Tang, James W Welsh, David Hong
Developmental Disabilities Research Reviews
|
December 17, 2009
Cognitive profile of Turner syndrome
David Hong, Jamie Scaletta Kent, Shelli Kesler
Cell Cycle (Georgetown, Tex.)
|
March 14, 2014
MET in ovarian cancer: metastasis and resistance?
Chad Tang, Denis L Jardim, David Hong
Journal of Multivariate Analysis
|
February 20, 2019
Asymptotic performance of PCA for high-dimensional heteroscedastic data
David Hong, Laura Balzano, Jeffrey A Fessler
SIAM Journal on Mathematics of Data Science
|
January 30, 2026
Optimally Weighted PCA for High-Dimensional Heteroscedastic Data
David Hong, Fan Yang, Jeffrey A Fessler, et al.
Page
of 28
Search research articles
Search
Showing results (1-10 of 272) with videos related to
Sort By:
Page
of 28
Pediatric Annals
|
April 2, 2026
Burn and Scald Injuries: Prevention and Anticipatory Guidance
David Hong
Journal of Immunotherapy and Precision Oncology
|
September 2, 2024
How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience
Razelle Kurzrock, David Hong
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 28, 2019
Hypersensitivity to monoclonal antibodies used for cancer and inflammatory or connective tissue diseases
David Hong, David E Sloane
Current Allergy and Asthma Reports
|
June 24, 2016
Immediate Drug Hypersensitivity
Paige G Wickner, David Hong
International Journal of Hematology
|
December 16, 2011
Anticoagulation-induced severe bleeding in a patient receiving bevacizumab therapy
Javier Munoz, David Hong, Razelle Kurzrock
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 4, 2017
Phase I Trial: SABR and Ipilimumab-Response
Chad Tang, James W Welsh, David Hong
Developmental Disabilities Research Reviews
|
December 17, 2009
Cognitive profile of Turner syndrome
David Hong, Jamie Scaletta Kent, Shelli Kesler
Cell Cycle (Georgetown, Tex.)
|
March 14, 2014
MET in ovarian cancer: metastasis and resistance?
Chad Tang, Denis L Jardim, David Hong
Journal of Multivariate Analysis
|
February 20, 2019
Asymptotic performance of PCA for high-dimensional heteroscedastic data
David Hong, Laura Balzano, Jeffrey A Fessler
SIAM Journal on Mathematics of Data Science
|
January 30, 2026
Optimally Weighted PCA for High-Dimensional Heteroscedastic Data
David Hong, Fan Yang, Jeffrey A Fessler, et al.
Page
of 28